Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(21/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(21/week)
News
United States
(578/week)
Manufacturing
(398/week)
Energy
(304/week)
Technology
(413/week)
Environment
(238/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Vosoritide
Aug 13, 2020
European Medicines Agency Validates BioMarin's Marketing Authorization Application for Vosoritide to Treat Children with Achondroplasia
Apr 06, 2020
BioMarin Plans Regulatory Submissions for Marketing Authorization of Vosoritide to Treat Children with Achondroplasia in 3Q 2020 in both US and Europe
Dec 16, 2019
BioMarin Announces Positive Final Results from Placebo-Controlled Phase 3 Data in Children with Achondroplasia Treated with Vosoritide
Nov 14, 2019
Poised for Significant Growth and Profitability, BioMarin Shares Company Highlights During R&D Day on November 14th in New York
Nov 14, 2019
BioMarin Announces Cumulative Additional Height Gain of 9.0 cm over 54 months versus Natural History in Children with Achondroplasia Treated with Vosoritide in Phase 2 Study
Nov 06, 2019
BioMarin to Highlight Innovative Development Pipeline at R&D Day on November 14th
Jun 18, 2019
BioMarin Announces New England Journal of Medicine Publishes Vosoritide Phase 2 Study Showing Sustained Annualized Growth Up to 42 Months in Children with Achondroplasia
Nov 01, 2018
BioMarin to Highlight Breadth of Innovative Development Pipeline at R&D Day on November 7th in New York
Jun 14, 2018
BioMarin Doses First Participant in Phase 2 Study of Vosoritide for Treatment of Infants and Young Children with Achondroplasia
Apr 25, 2018
BioMarin Announces First Quarter 2018 Financial Results
Oct 18, 2017
BioMarin Highlights Breadth of Innovative Development Pipeline at R&D Day on October 18th in New York
Oct 11, 2017
BioMarin to Highlight Breadth of Innovative Development Pipeline at R&D Day on October 18th in New York
Aug 02, 2017
BioMarin Announces Second Quarter 2017 Financial Results
Latest News
Apr 25, 2024
Universal Robots announces seamless integration with Siemens PLCs
Apr 25, 2024
Stak Mobility to Launch Second Mobility Hub in Pittsburgh; Sees Continued Momentum Across the US
Apr 25, 2024
DIC Algae Oil Sulfurized Extreme Pressure Additives Present Promising Alternatives to Lard Oils and Vegetable...
Apr 25, 2024
Multiply Labs and GenScript Biotech Corporation Collaborate to Automate the Cell Isolation and Enrichment...
Apr 25, 2024
Ranpak to Hold Conference Call to Discuss First Quarter 2024 Results
Apr 25, 2024
Nodal Exchange Announces Cooperation with Deutsche Börse Market Data + Services
Apr 25, 2024
Corporate Funding for Energy Storage Sector Totaled $11.7 Billion in Q1 2024
Apr 25, 2024
Empowering Innovation: StatLab Welcomes Scientific Device Laboratory Into Family
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events